unknown
Stage
1
Investors
About
Cardiosense develops FDA-authorized, noninvasive cardiac monitoring technology that provides real-time measurement of Pulmonary Capillary Wedge Pressure to improve heart failure patient management across care settings.
Explore Cardiosense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.